ClinicalTrials.gg
RecruitingNCT07413107Updated Feb 17, 2026

Development and Validation of the Italian Version of the Waddell Chronic Disability Index for People With Low Back Pain

An observational study in Low Back Pain, sponsored by Istituti Clinici Scientifici Maugeri SpA. Recruiting at 2 sites in Italy. Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2026-02-17.

Sponsored by Istituti Clinici Scientifici Maugeri SpA · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Jul 2026, 4 months ago, but the record still lists the study as recruiting.
  • Started Dec 2024; still recruiting 1 year 11 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Other
Time perspective
Other
Enrollment
115
Ages
18 Years to 90 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 56 studies in Low Back Pain with a site in Italy — 12 open to participants now, 13 under way, 1 of them phase 3. Low Back Pain · Italy.

Planned enrollment
7th of 15
115 · median 104
Started
2024
with 1 other
Observational
16 of 56
5 open now
Primary completion
2026-07
later than 9 of 12 live
Registered
52nd of 56
by date
Lead sponsor
2 of 56
Istituti Clinici Scientifici Maugeri SpA

Among the 56 studies in Low Back Pain with a site in Italy, this one is the 7th largest by planned enrollment of the 15 observational ones that give a count, is one of 2 that started in 2024, is one of 16 observational ones, reaches primary completion later than 9 of the 12 other live ones, and was the 52nd registered.

Low Back Pain

2,930 studies on the registry are indexed under Low Back Pain; 581 are open to participants now.

Browse Low Back Pain studies →

Open to participants now

12 of the 56 studies in Low Back Pain with a site in Italy are open now. Recruiting first, the newest first:

6 more — sign in →

All 12 open studies →

A study can be open while its sites in Italy have not opened yet or have stopped. Only those recruiting at a site in Italy →

Who these studies take

Of the 332 Low Back Pain studies recruiting now, 93 (28%) set no upper age limit and 209 (63%) stop at 75 or younger; 8 take children under 18; 46 take healthy volunteers.

This study: 18 Years to 90 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 56 studies in Low Back Pain with a site in Italy, or all of them as a file.
02

Study summary

This prospective observational study aims to develop and validate an Italian version of the Waddell Disability Index (WDI-I), a self-administered questionnaire designed to assess disability related to chronic low back pain. Low back pain is a leading cause of disability worldwide, and patient-reported outcome measures are increasingly recognized as essential tools for comprehensive clinical assessment and rehabilitation planning.

The study involves a standardized cross-cultural translation process, including forward and backward translations by bilingual translators and review by a panel of expert clinicians, followed by pilot testing. After consensus, the finalized Italian version (WDI-I) will undergo psychometric validation.

A total of 115 adult patients with chronic low back pain (≥3 months) will be recruited from two rehabilitation centers. At baseline, participants will complete the WDI-I along with the Numeric Pain Rating Scale (NPRS), the Italian Oswestry Disability Index (ODI-I), and the Italian Pain Catastrophizing Scale (PCS-I). The WDI-I will be re-administered after 7-10 days to assess test-retest reliability.

The primary endpoints are internal consistency, reliability, and construct validity of the WDI-I. Statistical analyses will include Cronbach's alpha and item-total correlations for internal consistency, intraclass correlation coefficients (ICC), standard error of measurement (SEM), and minimum detectable change (MDC) for reliability, and Spearman correlation coefficients to evaluate concurrent validity with established pain and disability measures.

The study seeks to provide a reliable and valid Italian instrument for assessing disability in individuals with chronic low back pain, facilitating both clinical practice and research

Read the detailed description

Rationale Low back pain is a very common condition and represents the leading cause of disability in industrialized countries, with a substantial economic and social impact.

The assessment of individuals with low back pain can be performed using physical tests (e.g., joint mobility, strength, gait) and outcome measures that evaluate pain intensity, functional limitations during daily activities, and quality of life. Over time, these latter measures have demonstrated strong reliability and validity, in some cases even surpassing the reliability and validity of physical tests. There is a growing consensus in the literature that such outcome measures, often self-completed by patients, represent an important complement to the overall assessment of individuals with low back pain and support the planning of rehabilitation programs. However, these measures are still viewed with some reluctance by healthcare professionals, despite not requiring additional assessment time and instead providing valuable supplementary information.

In this context, an outcome measure known as the Waddell Disability Index (WDI) exists. It was published in 1984 in the international journal Spine by Gordon Waddell and Chris Main and consists of a self-administered questionnaire including several activities of daily living, excluding work- and sport-related activities. The questionnaire is simple to administer and requires approximately five minutes to complete.

Considering the epidemiological background, the need for appropriate assessment tools, and the absence of a culturally adapted Italian version of the WDI, it is considered useful to develop an Italian adaptation of the WDI in individuals with low back pain and to analyze its reliability and validity properties.

Objectives The objective of this study is to produce an Italian-language version of the WDI through a cross-cultural translation procedure and to validate it in terms of internal consistency, reliability, and validity in a population of patients with chronic low back pain.

Endpoints

To demonstrate that the Italian version of the WDI is internally consistent, reliable, and correlated with the following scales:

  • Numeric Pain Rating Scale (NPRS)
  • Oswestry Disability Index - Italian version (ODI-I)
  • Pain Catastrophizing Scale - Italian version (PCS-I)

Population Patients A total of 115 patients referred to the Istituti Clinici Scientifici Maugeri for outpatient medical evaluation for chronic low back pain will be enrolled.

65 patients will be recruited from the Neuromotor Rehabilitation Unit of the Scientific Institute of Tradate 50 patients will be recruited from the Neuromotor Rehabilitation Unit of the Scientific Institute of Lissone

Inclusion Criteria

  • Age between 18 and 90 years
  • Ability to speak and understand Italian fluently
  • Low back pain lasting at least 3 months

Exclusion Criteria

  • Cognitive impairment (Mini Mental State Examination \< 24)
  • Central or peripheral neurological disorders
  • Systemic diseases or severe comorbidities (acute cardiac events, acute neurological events, chronic liver or kidney disease)
  • Uncorrected visual impairment
  • Individuals receiving compensation related to work-related disability

Translators Two native English-speaking translators One Italian language teacher (voluntary contribution)

Study Design An Italian-language version of the questionnaire will be developed through a standardized procedure involving translators and a group of five experienced clinicians.

Initially, each clinician independently produces a translated version of the scale together with the Italian-speaking translator. A synthesis process then leads to a single translated version, which is submitted to the two native English-speaking translators, each of whom performs a back-translation. The equivalence between the back-translations and the original version is then verified.

The resulting version is pilot-tested in an initial group of 15 patients (three patients per clinician).

After confirming applicability and reaching consensus, the final version (WDI-I) is defined.

At the two institutes (Tradate and Lissone), 50 patients each will be included in the final validation study, accounting for an expected dropout rate of 10%.

At time point T0, the following assessments are collected in a single session:

  • WDI-I
  • Numeric Pain Rating Scale (NPRS)
  • Oswestry Disability Index - Italian version (ODI-I)
  • Pain Catastrophizing Scale - Italian version (PCS-I) After 7-10 days, the WDI-I will be administered again to assess test-retest reliability.

Type of Study Prospective observational study

Sample Size The sample size was determined based on standard practice, as no formal sample size calculation exists for validation studies. Ten patients per item were recruited, with an additional 10% to account for possible dropouts. An extra 15 patients were included for the pilot study, resulting in a total of 115 patients.

Collected Variables

  • WDI-I: Italian version of the WDI obtained through the translation procedure. The WDI is a self-administered questionnaire consisting of 9 items related to the impact of low back pain on activities of daily living. Each item is scored as positive (1 point) or negative (0 points). The total score ranges from 0 (no disability) to 9 (maximum disability).
  • NPRS: An 11-point unidimensional scale assessing pain intensity in adults, ranging from 0 (no pain) to 10 (worst imaginable pain).
  • ODI-I: A self-administered questionnaire considered the current gold standard for assessing disability in patients with chronic low back pain. It consists of 10 items, each with 6 response options scored from 0 to 5. The total score is converted into a percentage, with 0% indicating no disability and 100% indicating complete disability.
  • PCS-I: A self-administered questionnaire assessing pain catastrophizing. It consists of 13 items scored from 0 (never) to 4 (always). The maximum total score is 52 points and includes three subscales: Rumination (items 8, 9, 10, 11); Magnification (items 6, 7, 13); Helplessness (items 1, 2, 3, 4, 5, 12)

Data Monitoring and Collection A dedicated data collection form will be prepared for each patient, including demographic and clinical data as well as the results of the clinical scales specified in the protocol.

Patient data will be pseudonymized and processed in accordance with Article 13 of EU Regulation 2016/679 (GDPR).

Statistical Analysis Methods

The statistical methods used to analyze the psychometric properties of the WDI-I include:

-Internal Consistency Internal consistency (the extent to which items measure the same construct) will be calculated using Cronbach's alpha and item-total correlations.

α > 0.90 is considered excellent (values > 0.95 may indicate item redundancy), α between 0.80-0.89 is considered good, and α between 0.70-0.79 is acceptable.

Item-total correlation assesses how well each item correlates with the total score, excluding that item. A minimum acceptable value of 0.40 is used.

Reliability Analysis Test-retest reliability will be evaluated to assess the stability of WDI-I scores across two administrations. The Intraclass Correlation Coefficient (ICC; two-way random, absolute agreement) with a 95% confidence interval will be calculated.

Agreement analysis, reflecting absolute measurement error, will include:

  • Standard Error of Measurement (SEM) calculated as SD × √(1 - ICC);
  • Minimum Detectable Change at 95% confidence (MDC95) MDC95 = 1.96 × SEM × √2

Validity Analysis Construct validity will be assessed by examining correlations with other concurrently administered measures. Concurrent validity will be quantified using Spearman's rank correlation coefficient between WDI-I scores and NPRS, ODI-I, and PCS-I scores.

Correlation coefficients will be interpreted as: 0.75: excellent; 0.50-0.75: moderate to good; 0.25-0.50: fair.

03

Conditions studied

  • Low Back Pain

Browse trials for

Keywords

  • Waddell Disability Index
  • Low Back Pain
  • questionnaire
  • Italian
  • Validation
04

Who can participate

Ages eligible
18 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients referred to the Istituti Clinici Scientifici Maugeri for outpatient medical evaluation for chronic low back pain will be enrolled

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Ability to speak and understand Italian fluently
  • Low back pain lasting at least 3 months

Exclusion criteria

Exclusion Criteria:

  • Cognitive impairment ( \< 24)
  • Central or peripheral neurological disorders
  • Systemic diseases or severe comorbidities (acute cardiac events, acute neurological events, chronic liver or kidney disease)
  • Uncorrected visual impairment
  • Individuals receiving compensation related to work-related disability
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

05

Study design

Observational model
Other
Time perspective
Other
Enrollment
115 participants (estimated)
Patient registry
No

Groups and cohorts

  • Chronic low back pain

    Patients with chronic low back pain (≥3 months)

06

What researchers measure

Primary outcomes

  1. Internal consistency

    Internal consistency is a measure of how well the items (questions) within a questionnaire work together to assess the same underlying construct or concept. It will be measured with Cronbach's alpha and item-total correlation.

    Time frame: Through study completion, an average of 1 year

  2. Reliability

    Reliability is the extent to which an instrument yields the same results when measurements are repeated under identical or similar conditions

    Time frame: Through study completion, an average of 1 year

  3. Construct Validity

    Construct validity refers to the extent to which a questionnaire actually measures the theoretical construct it is intended to measure. It reflects how well the instrument aligns with theoretical expectations.

    Time frame: Through study completion, an average of 1 year

07

Study locations

2 of 2 sites recruiting
  • ICS Maugeri - Lissone
    Lissone, Milano 20851, Italy
    Recruiting
  • IRCCS Maugeri - Tradate
    Tradate, VA 21049, Italy
    Recruiting
08

References and documents

Publications

  • Boateng GO, Neilands TB, Frongillo EA, Melgar-Quinonez HR, Young SL. Best Practices for Developing and Validating Scales for Health, Social, and Behavioral Research: A Primer. Front Public Health. 2018 Jun 11;6:149. doi: 10.3389/fpubh.2018.00149. eCollection 2018. PubMed 29942800 ↗
  • Cheng X, Xue R. Cross-cultural adaptation and validation of simplified Chinese version of the Waddell Disability Index for patients with nonspecific low back pain in Mainland China. Medicine (Baltimore). 2023 Jul 7;102(27):e34344. doi: 10.1097/MD.0000000000034344. PubMed 37417595 ↗
  • Waddell G, Main CJ. Assessment of severity in low-back disorders. Spine (Phila Pa 1976). 1984 Mar;9(2):204-8. doi: 10.1097/00007632-198403000-00012. PubMed 6233713 ↗
09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Dec 2024 (actual). Primary completion is estimated for Jul 2026, 19 months after the start.

Of 177 non-industry observational studies under Low Back Pain, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 48. This study's planned 19 months is below that.

Counting every sponsor, half of 187 studies reached it within 24 months; a quarter within 10 and three quarters within 48.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 30, 2026
First posted
Feb 17, 2026
StartActual
Dec 16, 2024
Primary completionEst.
Jul 2026
CompletionEst.
Dec 2026
Last update
Feb 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 17, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07413107
Responsible party
Sponsor
First posted
Feb 17, 2026
Start date
Dec 16, 2024
Primary completion
Jul 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
Feb 17, 2026

Study contacts

Umberto Massi
Contact
umberto.massi@icsmaugeri.it
+393517169176

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion